ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.
Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.
Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.
Bush Appoints Seven to NCAB, Designates Runowicz as Chairman.
IOM Report Recommends Solutions to Problem of Medication Errors.
Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.
Trending Stories
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors









